Fig A.This chart shows the similarities in outcomes between standard blood transfusions and hydroxyurea treatment in re-ducing transcranial Doppler velocities among patients with sickle cell disease.


Featured Research

Sickle Cell Breakthrough: A Pill to Replace Blood Transfusions

The 25-center TWiTCH clinical trial to evaluate hydroxyurea as a stroke prevention therapy was so successful that officials ended the study early.

Read More

Division Summary

Research and Training Details

Joint Appointment Faculty2
Research Fellows and Post Docs5
Research Graduate Students1
Total Annual Grant Award Dollars$2,939,144
Total Annual Industry Award Dollars$365,245
Total Publications46

Clinical Activities and Training

Clinical Fellows4
Inpatient Encounters1,346
Outpatient Encounters5,859